There was an error in the original publication [] comprising a misstatement of the text regarding NanoPac. A correction has been made to:
- -
- Section 4, Subsection 4.1.1, through the removal of “One of the studies has shown that NanoPac is responsible for inducing tumor in an in vivo model [37], while another study has provided the detail on its pharmacokinetics profile [38] and ability to reduce tumor regression [39]” and the removal of references 37, 38, and 39;
- -
- Table 2, Column “Outcome”, through the removal of “lower percentage area stenosis; improved neointimal proliferation and reduced tumor regression” and the addition of “more studies needed to be carried out for assessing the actual potential”.
With these corrections, the order of some references have been adjusted accordingly. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Qamar, S.U.R.; Spahić, L.; Benolić, L.; Zivanovic, M.; Filipović, N. Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. Pharmaceutics 2023, 15, 1813. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).